Have a personal or library account? Click to login
Knowledge and Attitude of Dentists Regarding Patients Undergoing Bisphosphonate Treatment: a Comparative Questionnaire Cover

Knowledge and Attitude of Dentists Regarding Patients Undergoing Bisphosphonate Treatment: a Comparative Questionnaire

Open Access
|Dec 2018

References

  1. 1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117.10.1016/S0278-2391(03)00720-1
  2. 2. Ruggiero SL, Dodson TB, Assael LA, et al. American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.10.1016/j.joms.2009.01.009
  3. 3. Pittman K, Antill YC, Goldrick A, Goh J, de Boer RH. Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures. Asia Pac J Clin Oncol. 2017;13:266-276.10.1111/ajco.12517
  4. 4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534.10.1016/j.joms.2004.02.004
  5. 5. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther. 2002;302:1055-1061.10.1124/jpet.102.035295
  6. 6. Yamashita J, McCauley LK. Antiresorptives and osteonecrosis of the jaw. J Evid Base Dent Pract. 2012:S1:233-247.10.1016/S1532-3382(12)70046-5
  7. 7. Saia G, Blandamura S, Bettini G, et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg. 2010;68:797-804.10.1016/j.joms.2009.10.02620307765
  8. 8. Conte Neto N, Spolidorio LC, Andrade CR, Bastos S, Guimarães A, Marcantonio ME Jr. Experimental development of bisphosphonate-related osteonecrosis of the jaws in rodents. Int J Exp Pathol. 2013;94:65-73.10.1111/iep.12007357587523317355
  9. 9. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment. J Oral Maxillofac Surg. 2005;63:1567-1575.10.1016/j.joms.2005.07.01016243172
  10. 10. Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW, Sedghizadeh PP. The role of microbial biofilms in osteonecrosis of the jaw associated with bisphosphonate therapy. Curr Osteoporos Rep. 2010;8:40-48.10.1007/s11914-010-0008-120425090
  11. 11. Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N. Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporosis International. 2013;24:237-244.10.1007/s00198-012-2042-622707065
  12. 12. Walter C, Al-Nawas B, Grotz KA, et al. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate. European Urology. 2008;54:1066-1072.10.1016/j.eururo.2008.06.07018602738
  13. 13. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors. J Clin Oncol. 2006;24:945.10.1200/JCO.2005.04.246516484704
  14. 14. Ruggiero SL, Dodson TB, Fantasia J, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. J Oral Maxillofac Surg. 2014;72:1938-1956.10.1016/j.joms.2014.04.03125234529
  15. 15. Albu IA, Petrovan C, Păcurar M, et al. Biophosphonate-Related Osteonecrosis of the Jaws: A Real Challenge for Dentists. Acta Medica Marisiensis. 2015;61:115-119.10.1515/amma-2015-0034
  16. 16. Mercer E, Norton T, Woo S, Treister N, Dodson TB, Solomon DH. Ninety-one osteoporosis patients affected with bisphosphonate-related osteonecrosis of the jaw: a case series. Calcif Tissue Int. 2013;93:241-248.10.1007/s00223-013-9747-1374462123756612
  17. 17. Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N. Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg. 2009;67:850-855.10.1016/j.joms.2008.11.01519304045
  18. 18. Nicolatou-Galitis O, Papadopoulou E, Sarri T, et al. Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:195-202.10.1016/j.tripleo.2011.02.03721622014
  19. 19. Hallmer F, Bjørnland T, Nicklasson A, Becktor JP, Andersson G. Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:202-208.10.1016/j.oooo.2014.05.00625047929
  20. 20. Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S. Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg. 2012;40:277-282.10.1016/j.jcms.2011.04.01121612939
  21. 21. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg. 2009;67:61-70.10.1016/j.joms.2009.01.00719371816
  22. 22. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc. 2005;136:1658-1668.10.14219/jada.archive.2005.010816383047
  23. 23. Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D. Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Dis. 2012;18:85-95.10.1111/j.1601-0825.2011.01848.x323232721883710
  24. 24. Berti-Couto SA, Vasconcelos AC, Iglesias JE, Figueiredo MA, Salum FG, Cherubini K. Diabetes mellitus and corticotherapy as risk factors for alendronate-related osteonecrosis of the jaws: a study in Wistar rats. Head Neck. 2014;36:84-93.10.1002/hed.2326023649954
  25. 25. Drake MT, Clarke BL, Lewiecki EM. The Pathophysiology and Treatment of Osteoporosis. Clin Ther. 2015;37:1837-1850.10.1016/j.clinthera.2015.06.00626163201
DOI: https://doi.org/10.2478/jim-2018-0027 | Journal eISSN: 2501-8132 | Journal ISSN: 2501-5974
Language: English
Page range: 169 - 172
Submitted on: Jun 12, 2018
Accepted on: Jul 28, 2018
Published on: Dec 19, 2018
Published by: Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Ioana-Aurița Albu-Stan, Cecilia Petrovan, Diana Cerghizan, Lia Yero Eremie, Adriana Elena Crăciun, Constantin Copotoiu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.